Occurrence of Adverse Effects With Immune Checkpoint Inhibitors Between a Single and Double Dose Regimen
Clinical trial NCT04956783 · COMPLETED
Trial details
- NCT number
- NCT04956783
- Sponsor
- University Hospital, Montpellier
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-06-01
- Primary completion
- 2021-06-30
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.